Abstract
BackgroundThe long-term immune-suppressive effects of Disease Modifying anti-Rheumatic Drugs (DMARDs) have long been a concern for serious adverse effects (SAE).Other developing countries, e.g. Brazil, used their registry to report a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
